Skip to main content

Advertisement

Log in

Cortical Excitability in Chronic Migraine

  • Chronic Daily Headache (SJ Wang, Section Editor)
  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

A proportion of episodic migraine patients experiences a progressive increase in attack frequency leading to chronic migraine (CM). The most frequent external factor that leads to headache chronification is medication overuse. The neurobiological bases of headache chronification and of the vicious circle of medication overconsumption are not completely elucidated. More recently, the same neurophysiological methods used to study episodic migraine were applied to CM and medication-overuse headache (MOH). Studies of cortical responsivity tend overall to indicate an increase in excitability, in particular of somatosensory and visual cortices, reflected by increased amplitude of evoked responses, decreased activity of inhibitory cortical interneurons reflected in the smaller magnetic suppression of perceptual accuracy, and, at least for visual responses, an increase in habituation. In MOH, overconsumption of triptans or NSAIDs influences cortical excitability differently. Generalized central sensitization is suggested to play an important role in the pathophysiology of headache chronification.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. Olesen J, Bousser MG, Diener HC, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006;26(6):742–6.

    Article  PubMed  CAS  Google Scholar 

  2. Diener HC, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet Neurol. 2004;3(8):475–83.

    Article  PubMed  Google Scholar 

  3. Silberstein SD, Olesen J, Bousser MG, et al. International Headache Society: the International Classification of Headache Disorders, 2nd Edition (ICHD-II)–revision of criteria for 8.2 Medication-overuse headache. Cephalalgia. 2005;25(6):460–5.

    Article  PubMed  CAS  Google Scholar 

  4. Wang SJ, Fuh JL, Lu SR, et al. Chronic daily headache in Chinese elderly: prevalence, risk factors, and biannual follow-up. Neurology. 2000;54(2):314–9.

    PubMed  CAS  Google Scholar 

  5. Bigal ME, Lipton RB. Modifiable risk factors for migraine progression. Headache. 2006;46(9):1334–43.

    Article  PubMed  Google Scholar 

  6. Coppola G, Pierelli F, Schoenen J. Is the cerebral cortex hyperexcitable or hyperresponsive in migraine? Cephalalgia. 2007;27(12):1427–39.

    Article  PubMed  CAS  Google Scholar 

  7. Treede R, Lorenz J, Baumgärtner U. Clinical usefulness of laser-evoked potentials. Neurophysiol Clin. 2003;33(6):303–14.

    Article  PubMed  Google Scholar 

  8. de Tommaso M, Difruscolo O, Sardaro M, et al. Effects of remote cutaneous pain on trigeminal laser-evoked potentials in migraine patients. J Headache Pain. 2007;8(3):167–74.

    Article  PubMed  Google Scholar 

  9. de Tommaso M, Valeriani M, Guido M, et al. Abnormal brain processing of cutaneous pain in patients with chronic migraine. Pain. 2003;101(1–2):25–32.

    Article  PubMed  Google Scholar 

  10. de Tommaso M, Baumgartner U, Sardaro M, et al. Effects of distraction versus spatial discrimination on laser-evoked potentials in migraine. Headache. 2008;48(3):408–16.

    Article  PubMed  Google Scholar 

  11. de Tommaso M, Losito L, Difruscolo O, et al. Changes in cortical processing of pain in chronic migraine. Headache. 2005;45(9):1208–18.

    Article  PubMed  Google Scholar 

  12. Ayzenberg I, Obermann M, Nyhuis P, et al. Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures. Cephalalgia. 2006;26(9):1106–14.

    Article  PubMed  CAS  Google Scholar 

  13. Groves PM, Thompson RF. Habituation: a dual-process theory. Psychol Rev. 1970;77(5):419–50.

    Article  PubMed  CAS  Google Scholar 

  14. Rankin CH, Abrams T, Barry RJ, et al. Habituation revisited: an updated and revised description of the behavioral characteristics of habituation. Neurobiol Learn Mem. 2009;92(2):135–8.

    Article  PubMed  Google Scholar 

  15. Ozkul Y, Uckardes A. Median nerve somatosensory evoked potentials in migraine. Eur J Neurol. 2002;9(3):227–32.

    Article  PubMed  CAS  Google Scholar 

  16. •• Coppola G, Currà A, Di Lorenzo C, et al: Abnormal cortical responses to somatosensory stimulation in medication-overuse headache. BMC Neurol 2010, 10:126. This study showed that the somatosensory cortex becomes persistently sensitized with medication overuse. The sensitization is obvious in patients overusing NSAIDs and almost nonexistent or masked in those who overuse only triptans.

  17. Birbaumer N, Elbert T, Canavan AG, Rockstroh B. Slow potentials of the cerebral cortex and behavior. Physiol Rev. 1990;70(1):1–41.

    PubMed  CAS  Google Scholar 

  18. Siniatchkin M, Gerber WD, Kropp P, Vein A: Contingent negative variation in patients with chronic daily headache. Cephalalgia 1998, 18(8):565–9; discussion 531.

    Google Scholar 

  19. •• Chen WT, Wang SJ, Fuh JL, et al: Persistent ictal-like visual cortical excitability in chronic migraine. Pain. 2011, 152(2):254–258. This study showed, for the first time, that the response pattern of the visual cortex in patients with CM is similar to that found during a common migraine attack in patients with episodic migraine.

  20. Chen WT, Lin YY, Fuh JL, et al. Sustained visual cortex hyperexcitability in migraine with persistent visual aura. Brain. 2011;134(Pt 8):2387–95.

    Article  PubMed  Google Scholar 

  21. Aurora S, Barrodale P, Chronicle E, Mulleners W. Cortical inhibition is reduced in chronic and episodic migraine and demonstrates a spectrum of illness. Headache. 2005;45(5):546–52.

    Article  PubMed  Google Scholar 

  22. Aurora S, Barrodale P, Tipton R, Khodavirdi A. Brainstem dysfunction in chronic migraine as evidenced by neurophysiological and positron emission tomography studies. Headache. 2007;47(7):996–1003.

    Article  PubMed  Google Scholar 

  23. Brighina F, Piazza A, Vitello G, et al. rTMS of the prefrontal cortex in the treatment of chronic migraine: a pilot study. J Neurol Sci. 2004;227(1):67–71.

    Article  PubMed  Google Scholar 

  24. Currà A, Coppola G, Gorini M, et al. Drug-induced changes in cortical inhibition in medication overuse headache. Cephalalgia. 2011;31(12):1282–90.

    Article  PubMed  Google Scholar 

  25. Cruccu G, Inghilleri M, Berardelli A, et al. Cortical mechanisms mediating the inhibitory period after magnetic stimulation of the facial motor area. Muscle Nerve. 1997;20(4):418–24.

    Article  PubMed  CAS  Google Scholar 

  26. Panconesi A. Serotonin and migraine: a reconsideration of the central theory. J Headache Pain. 2008;9(5):267–76.

    Article  PubMed  CAS  Google Scholar 

  27. Ferrari MD, Saxena PR. On serotonin and migraine: a clinical and pharmacological review. Cephalalgia. 1993;13(3):151–65.

    Article  PubMed  CAS  Google Scholar 

  28. Evers S, Quibeldey F, Grotemeyer KH, et al. Dynamic changes of cognitive habituation and serotonin metabolism during the migraine interval. Cephalalgia. 1999;19(5):485–91.

    Article  PubMed  CAS  Google Scholar 

  29. Weiller C, May A, Limmroth V, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med. 1995;1(7):658–60.

    Article  PubMed  CAS  Google Scholar 

  30. Bahra A, Matharu MS, Buchel C, et al. Brainstem activation specific to migraine headache. Lancet. 2001;357(9261):1016–7.

    Article  PubMed  CAS  Google Scholar 

  31. Matharu MS, Bartsch T, Ward N, et al. Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain. 2004;127(Pt 1):220–30.

    Article  PubMed  Google Scholar 

  32. Schoenen J. Is chronic migraine a never-ending migraine attack? Pain. 2011;152(2):239–40.

    Article  PubMed  Google Scholar 

  33. Afra J, Proietti Cecchini A, Sándor PS, Schoenen J. Comparison of visual and auditory evoked cortical potentials in migraine patients between attacks. Clin Neurophysiol. 2000;111(6):1124–9.

    Article  PubMed  CAS  Google Scholar 

  34. Burstein R, Cutrer MF, Yarnitsky D. The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain. 2000;123(Pt 8):1703–9.

    Article  PubMed  Google Scholar 

  35. Kaube H, Katsarava Z, Przywara S, et al. Acute migraine headache: possible sensitization of neurons in the spinal trigeminal nucleus? Neurology. 2002;58(8):1234–8.

    PubMed  CAS  Google Scholar 

  36. Lovati C, D'Amico D, Bertora P, et al. Acute and interictal allodynia in patients with different headache forms: an Italian pilot study. Headache. 2008;48(2):272–7.

    Article  PubMed  Google Scholar 

  37. Bigal ME, Ashina S, Burstein R, et al. Prevalence and characteristics of allodynia in headache sufferers: a population study. Neurology. 2008;70(17):1525–33.

    Article  PubMed  CAS  Google Scholar 

  38. Dodick D, Silberstein S. Central sensitization theory of migraine: clinical implications. Headache. 2006;4:S182–91.

    Article  Google Scholar 

  39. Schmidt-Wilcke T, Leinisch E, Straube A, et al. Gray matter decrease in patients with chronic tension type headache. Neurology. 2005;65(9):1483–6.

    Article  PubMed  CAS  Google Scholar 

  40. Fumal A, Laureys S, Di Clemente L, et al. Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain. 2006;129(Pt 2):543–50.

    PubMed  Google Scholar 

  41. Woolf CJ, Wall PD. Relative effectiveness of C primary afferent fibers of different origins in evoking a prolonged facilitation of the flexor reflex in the rat. J Neurosci. 1986;6(5):1433–42.

    PubMed  CAS  Google Scholar 

  42. Thompson RF, Spencer WA. Habituation: a model phenomenon for the study of neuronal substrates of behavior. Psychol Rev. 1966;73(1):16–43.

    Article  PubMed  CAS  Google Scholar 

  43. Limmroth V, Katsarava Z, Fritsche G, et al. Features of medication overuse headache following overuse of different acute headache drugs. Neurology. 2002;59(7):1011–4.

    PubMed  CAS  Google Scholar 

  44. De Felice M, Ossipov MH, Wang R, et al. Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers. Brain. 2010;133(Pt 8):2475–88.

    Article  PubMed  Google Scholar 

  45. Katsarava Z, Fritsche G, Muessig M, et al. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology. 2001;57(9):1694–8.

    PubMed  CAS  Google Scholar 

  46. Stankewitz A, May A. The phenomenon of changes in cortical excitability in migraine is not migraine-specific–a unifying thesis. Pain. 2009;145(1–2):14–7.

    Article  PubMed  Google Scholar 

Download references

Disclosures

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jean Schoenen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Coppola, G., Schoenen, J. Cortical Excitability in Chronic Migraine. Curr Pain Headache Rep 16, 93–100 (2012). https://doi.org/10.1007/s11916-011-0231-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-011-0231-1

Keywords

Navigation